Seattle Genetics Inc. (SGEN) Tops Q3 EPS by 11c
Tweet
Share
E-mailGet Alerts SGEN Hot Sheet
Price: $228.74 --0%
Financial Fact:
Research and development: 92.71M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research and development: 92.71M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Seattle Genetics Inc. (NASDAQ: SGEN) reported Q3 EPS of ($0.35), $0.11 better than the analyst estimate of ($0.46). Revenue for the quarter came in at $20 million versus the consensus estimate of $13.57 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
